FDA Approves At-Home Starting Dose for Lecanemab - Top-Institutions - MDSpire

FDA Approves At-Home Starting Dose for Lecanemab

Patients may begin lecanemab-irmb treatment at home through self-administration or administration by a caregiver, according to the FDA.

  • By

  • Kathryn Wighton

  • July 13, 2026

  • 3 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    University of Colorado
    University of Colorado

    Aurora, CO

    Key Differentiators

    • Neurology

  • #2

    City of Hope
    City of Hope

    Duarte, CA

    Key Differentiators

    • Oncology
    • Neurology

  • #3

    Children’s Hospital of Philadelphia
    Children’s Hospital of Philadelphia

    Philadelphia, PA

    Key Differentiators

    • Pediatrics
    • Neurology

  • #4

    Northwestern University
    Northwestern University

    Chicago, IL

    Key Differentiators

    • Neurology

  • #5

    Moffitt Cancer Center
    Moffitt Cancer Center

    Tampa, FL

    Key Differentiators

    • Oncology
    • Neurology

Original Source(s)

FDA Approves At-Home Starting Dose for Lecanemab

  • by Kathryn Wighton

  • July 13, 2026

Related Content

Diet-Dementia Link Varies by Biomarkers

Effects varied by which biomarker and diet were measured, and the study stops short of proving diet changes risk.

Mediterranean Diet Linked to Higher Levels of Mitochondrial Microproteins

Greater adherence was associated with lower oxidative stress markers in older patients.

Aid in Dying Nears One Third of US

New laws in New York and Illinois will soon make medical aid in dying available to nearly one-third of Americans.